“Navigating the treatment of substance use disorder and schizophrenia spectrum disorder in the concurrent disorders’ population – an overview and update”
Dr. Alexandra Anghel
Addiction Medicine Fellow, BC Centre on Substance Use
Tuesday, April 26
12pm – 1pm
Learning objectives:
- Appreciate the relationship and epidemiological trends between substance use in patients with schizophrenia spectrum disorders
- Review the current evidence of evidence-based pharmacological practices that improve outcomes for individuals with schizophreniaspectrum disorder and comorbid substance use disorder
- Understand the efficacy, tolerability and choice of antipsychotics in individuals with schizophrenia and comorbid substance use disorder
What’s New in Addiction Medicine is a lunch-time series featuring clinicians and researchers who will deliver the latest research and information on novel, evidence-based addiction medicine topics.
This free series is geared towards the needs and interests of individuals operating in a healthcare or research setting, however, the public and other interested stakeholders are welcome and encouraged to attend.
If you have any questions about event logistics, please contact Raman Jawanda at [email protected].